Skip to main content
Caplight Logo









SynDermix AG

SynDermix AG

Private
HünenbergHealthcare & Life Scienceshttps://syndermix.ch/

Last Round

Early Funding

Dec 1, 2018

Total Funding Raised

$10.1M

Company Overview

SynDermix AG is a biotechnology company that acquires, develops, and commercializes a portfolio of assets in the MedTech, Pharma, and Biotech sectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologymedical devicepharmaceutical developmentvirtual biotechcosmeceuticalsdrug discoveryin-licensingasset-centricout-licensingskincarenitric oxide therapeuticsacoustic medical devicesbiotech holding companypharma incubator

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SynDermix AG Comparables

Compare SynDermix AG with similar companies based on industry and business-model similarity.

SynDermix AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Remedor Biomed Ltd.
67%
Debiopharm Group
66%
Fortress Biotech
65%

SynDermix AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingDec 1, 2018

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2025

    Monthly visitors grew 2686% MoM, from 7 to 195.

  • Dec 1, 2018

    $10.1M raised in early funding.

SynDermix AG Filings

Explore SEC and related filing metadata, where available.

SynDermix AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SynDermix AG's valuation, stock price, and market status.

Is SynDermix AG a public or private company?

SynDermix AG is a private company.

What is the current stock price of SynDermix AG?

SynDermix AG is a private company with no public stock price. Caplight tracks SynDermix AG's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is SynDermix AG worth (valuation)?

Valuation information for SynDermix AG is not publicly available.

Can I buy SynDermix AG stock?

SynDermix AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SynDermix AG's last funding round?

SynDermix AG's most recent funding round was Early Funding on December 1, 2018.

Who are the main investors in SynDermix AG?

Investor information for SynDermix AG is not publicly disclosed.

Will SynDermix AG IPO soon?

No public IPO plans have been announced for SynDermix AG.

How can I track SynDermix AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SynDermix AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHünenberg
Year Founded2009
Last FundingDec 1, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?